BioSpace News Archive

4D Molecular Therapeutics, a clinical-stage leader in the development of precision-guided AAV gene medicines based on directed evolution, announced a new agreement with Cystic Fibrosis Foundation to develop precision gene medicines for cystic fibrosis.

John Wiley & Sons Inc., a global leader in research and education, and the Institution of Engineering and Technology announced their open access publishing partnership, transitioning the IET journal program to gold open access from January 2021.

ISTURISA® (osilodrostat) demonstrates significant and sustained benefit over placebo at normalizing mean urinary free cortisol (mUFC) levels in patients with Cushing’s disease

Phase 2 study results demonstrated the potential clinical benefit of exebacase, when used in addition to existing antibiotics, for the treatment of life-threatening MRSA bacteremia

Data adds to growing body of research in both human and animal cell lines supporting Brilacidin’s robust antiviral properties against SARS-CoV-2

Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced new information regarding its participation in two upcoming investor virtual conferences. Gerald McMahon, Ph.D., President and Chief Executive Officer, will now participate in: A fireside chat at the JMP Securities Hematology & Oncology Forum on Thursday, June 18, 2020 at 3:40 p.m. ET

Research may pinpoint way to save lives of approximately 20 percent of all COVID patients

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a biotechnology company focused on precisely targeted bacteriophage therapeutics for antibi

Praj Industries Ltd. and Lygos, Inc. have signed a Memorandum of Understanding to co-develop Lygos’s proprietary yeast for the production of lactic acid.

NTC Srl, an R&D focused pharmaceutical company headquartered in Italy, has granted exclusive license and distribution rights to one of its research and development products, a fixed combination in eye drops, in Israel to Taro Pharmaceutical Industries, a research-based international pharmaceutical company.